Evidence map›Paper›PMID 37810626›Full record

ReviewTranslational and clinical pharmacology2023

Transforming clinical trials: the emerging roles of large language models.

Jong-Lyul Ghim, Sangzin Ahn

Abstract readReview
In one paragraph

Review in Translational and clinical pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. AI-driven drug design: a comprehensive review.Journal of computer-aided molecular design · 2026
    Review
  4. Review
  5. Artificial Intelligence in Rhinology: A State-of-the-Art Review of Clinical Readiness and Implementation Pathways.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. The Emergence of AI in Public Health Is Calling for Operational Ethics to Foster Responsible Uses.International journal of environmental research and public health · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Transforming literature screening: The emerging role of large language models in systematic reviews.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jong-Lyul GhimDepartment of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Korea.ORCID https://orcid.org/0000-0002-6137-786X
Sangzin AhnCenter for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Korea.ORCID https://orcid.org/0000-0003-2749-0014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical trials are essential for medical research, but they often face challenges in matching patients to trials and planning. Large language models (LLMs) offer a promising solution, signaling a transformative shift in the field of clinical trials. This review explores the multifaceted applications of LLMs within clinical trials, focusing on five main areas expected to be implemented in the near future: enhancing patient-trial matching, streamlining clinical trial planning, analyzing free text narratives for coding and classification, assisting in technical writing tasks, and providing cognizant consent via LLM-powered chatbots. While the application of LLMs is promising, it poses challenges such as accuracy validation and legal concerns. The convergence of LLMs with clinical trials has the potential to revolutionize the efficiency of clinical trials, paving the way for innovative methodologies and enhancing patient engagement. However, this development requires careful consideration and investment to overcome potential hurdles.

Indexed as

Artificial IntelligenceClinical TrialInformed ConsentMedical WritingNatural Language Processing

Identifiers

PMID37810626
PMCPMC10551746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.